IO Biotech, Inc.
IOBT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $60 | $143 | $143 | $212 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $1 | $1 | $2 | $2 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4 | $3 | $4 | $8 |
| Total Curr. Assets | $65 | $147 | $148 | $222 |
| Property Plant & Equip (Net) | $2 | $3 | $3 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $3 | $3 | $4 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $68 | $151 | $152 | $222 |
| Liabilities | – | – | – | – |
| Payables | $5 | $4 | $4 | $4 |
| Short-Term Debt | $1 | $1 | $1 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $14 | $11 | $6 | $6 |
| Total Curr. Liab. | $19 | $16 | $11 | $10 |
| LT Debt | $1 | $2 | $2 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $1 | $2 | $2 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $2 | $2 | $0 |
| Total Liabilities | $21 | $18 | $13 | $10 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$359 | -$264 | -$178 | -$106 |
| AOCI | -$7 | -$10 | -$10 | -$1 |
| Other Equity | $413 | $407 | $327 | $320 |
| Total Equity | $47 | $133 | $139 | $212 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $68 | $151 | $152 | $222 |
| Net Debt | -$58 | -$141 | -$140 | -$212 |